As Canada works out how one can cope with calls from its southern neighbour to develop into the 51st US state, it’s increasing its personal invasion on a really totally different entrance.
Canadian hashish’ dominance within the European market is stronger than ever, and the monetary returns from a few of its largest gamers make it straightforward to see why.
However as operators flip to Europe to flee the saturated and intensely aggressive home Canadian market, might this flood of low cost, high-quality hashish into Europe merely export the issue?
Final 12 months, business giants Aurora Hashish and Excessive Tide posted spectacular earnings because of their growth efforts. Now, each firms are hoping to strengthen their foothold within the European market, betting that its urge for food for Canadian hashish will stay insatiable.
We spoke with Excessive Tide CEO Raj Grover and Aurora CEO Miguel Martin to debate their plans, and their outlook for the way forward for this provide chain.
The state of the Canadian hashish market
Having been one of many first international locations to legalise medical hashish in 2001, and having develop into the biggest nation to legalise adult-use hashish federally in 2018, Canada represents maybe essentially the most mature market on the planet.
Canada has additionally performed an important but usually neglected position within the ‘seeding’ of medical hashish markets world wide for the reason that implementation of the Marihuana for Medical Functions Laws (MMPR) in 2014.
As such, Canadian hashish has at all times had a presence in European markets, and ten years later, most international locations proceed to obtain a good portion of their market provide from Canadian producers.
Quite a few elements at the moment are supercharging this dynamic, seeing Canadian medical hashish exports within the first six months of 2024 practically double.
In the meantime, home gross sales have been underneath strain, declining by practically 13% within the final monetary 12 months, in line with Prohibition Companions’ newest International Hashish Report.
Because the European market has grown over the previous couple of years, each by way of dimension and in its acceptance of hashish, Canadian producers have more and more seemed in the direction of it to safe higher margins and fewer competitors, aided by many producers current adherence to EU GMP requirements.
European progress
One of many key benefactors (and instigators) of this has been Aurora, which reported complete web income of C$88.2 million in its newest quarter, a 37% enhance year-over-year.
It additionally reported a file web earnings of C$31.2 million, marking a 282% enhance from the prior 12 months, and achieved a file adjusted EBITDA of C$23.1 million, up 316% year-over-year.
This progress was primarily pushed by a 51% surge in world medical hashish income, which reached C$68.1 million and accounted for 77% of the corporate’s consolidated web income.
“A lot of our progress—if not all of it—has come from Europe and Australia,” Martin instructed Enterprise of Hashish.
“Our three main markets in Europe, shifting west to east, are Poland, Germany, and the UK. Australia can also be a serious marketplace for us.”
Requested whether or not he anticipated this stage of progress to proceed, Martin stated that whereas they might not preserve the identical ranges of seen in 2024, he expects ‘all of those markets to proceed rising.’
“Proper now, lower than 1% of the grownup inhabitants is a part of the medical system, which suggests there’s nonetheless vital room for growth. So long as the business strikes ahead in the best manner—and we definitely intend to do it the best manner—firms like ours can be well-positioned to navigate and reach these markets.”
Except for the upper margins it may possibly obtain promoting into the European medical market, avoiding Canada’s hefty tax levy, Martin factors out that working in a ‘extremely conservative medicinal pharmaceutical mannequin’ like medical hashish means Aurora is much less affected by market fluctuations.
Its Canadian stablemate, Excessive Tide, has been much less concerned within the European market up to now, however it’s engaged on altering that rapidly.
Final month, Excessive Tide introduced that it had acquired a 51% stake in Purecan GmbH, a German pharmaceutical wholesaler with established provide chains all through the nation and a license to import medical hashish.
The €4.8 million acquisition marks the corporate’s entrance into the thriving German medical hashish market.
Its CEO, Raj Grover, defined, “It has been two years within the making, as we’ve explored totally different entry factors into the profitable German market.”
Excessive Tide additionally had a standout 12 months in 2024, solidifying its place as Canada’s high revenue-generating hashish firm for the third consecutive 12 months.
Nonetheless, not like Aurora, its progress was largely discovered within the home adult-use market through an aggressive retail growth, opening 29 new Canna Cabana shops in 2024.
Initially, it had hoped to interrupt into Germany’s adult-use market, however given the quickly shifting political panorama, it seems that is considerably delayed, if not totally off the desk.
As such, Grover defined that its acquisition of PureCan types a part of its ‘secondary technique’ to interrupt into the market.
“At our core, we’re retailers. Our main enterprise is brick-and-mortar hashish retail, with 191 working shops throughout Canada. Our primary purpose was to enter Germany via bodily retail places.
“Nonetheless, the German authorities collapsed, impacting our preliminary plans. In response, we’ve partnered with a good tutorial establishment in Germany and engaged professors to help with a analysis pilot venture.
“This analysis initiative serves as our secondary technique for getting into the German market, and we discover ourselves well-positioned inside this evolving worth chain.”
Stick with Enterprise of Hashish for half two of our deep dive into Canadian hashish in Europe, set to be printed within the coming days.
